WGU D027
OBJECTIVE ASSESSMENT - EXAM
WGU D027 OA Exam Advanced
Pathopharmacological Foundations
Tested Questions (Latest 2026/2027)
and Verified Rationalized Answers
Advanced Pathopharmacological Foundations | WGU D027 2026/2027
50 100% 2026/2027
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
Cellular Pathophysiology & Genetics Respiratory & Renal Systems
Pharmacokinetics & Pharmacodynamics Endocrine & Immune Disorders
Cardiovascular Pathophysiology Neurological & Musculoskeletal
COVER PAGE - 1
,SECTION 1 | Foundations of Pathophysiology | Q1-Q10 | WGU D027 2026/2027
Q1 Question 1 of 50
A 62-year-old male patient with a 40-pack-year smoking history presents with progressive
dyspnea and a chronic productive cough. His pulmonary function tests reveal an
FEV1/FVC ratio of 0.58 and an FEV1 of 45% predicted. Which pathophysiological
mechanism best explains the progressive airflow limitation in this patient?
A. Destruction of alveolar walls leading to loss of elastic recoil
B. Chronic inflammation causing small airway fibrosis and mucus hypersecretion
C. Bronchial smooth muscle hypertrophy causing episodic bronchospasm
D. Pulmonary capillary endothelial damage leading to interstitial fibrosis
Correct Answer: B
Rationale:
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the small
airways, leading to fibrosis, mucus hypersecretion, and progressive airflow limitation. This matches the
patient's smoking history and fixed airflow obstruction pattern. While alveolar destruction (A) occurs in
emphysema, it is not the primary mechanism of airflow limitation. Episodic bronchospasm (C) is more typical
of asthma. Interstitial fibrosis (D) describes restrictive lung disease, not obstructive.
WGU D027 - 2026/2027 | Passing Score: 80% | Page 1 of 35
,SECTION 1 | Foundations of Pathophysiology | Q1-Q10 | WGU D027 2026/2027
Q2 Question 2 of 50
A 45-year-old female with systemic lupus erythematosus presents with acute onset of
hematuria, proteinuria, and rising serum creatinine. A renal biopsy reveals diffuse
proliferative glomerulonephritis with subendothelial immune complex deposits. Which
complement pathway is primarily activated by these immune complexes?
A. The classical pathway initiated by C1q binding to antibody Fc regions
B. The alternative pathway initiated by spontaneous C3 hydrolysis
C. The lectin pathway initiated by mannose-binding lectin recognition
D. The terminal pathway initiated by direct C5 activation
Correct Answer: A
Rationale:
Immune complex deposition in lupus nephritis activates the classical complement pathway through C1q
binding to the Fc regions of antibodies within the complexes. This leads to C3 convertase formation, C3b
deposition, and subsequent glomerular inflammation. The alternative pathway (B) is antibody-independent
and typically activated by microbial surfaces. The lectin pathway (C) responds to carbohydrate patterns on
pathogens. The terminal pathway (D) requires upstream activation and does not initiate independently.
WGU D027 - 2026/2027 | Passing Score: 80% | Page 2 of 35
, SECTION 1 | Foundations of Pathophysiology | Q1-Q10 | WGU D027 2026/2027
Q3 Question 3 of 50
A 58-year-old male with poorly controlled type 2 diabetes presents with numbness and
tingling in a stocking-glove distribution. Nerve conduction studies reveal slowed
conduction velocities and reduced amplitudes. Which metabolic derangement is the
primary driver of this peripheral neuropathy?
A. Accumulation of advanced glycation end-products causing basement membrane thickening
B. Chronic hyperglycemia leading to sorbitol accumulation via the polyol pathway
C. Insulin deficiency causing impaired fatty acid oxidation in Schwann cells
D. Elevated glucagon levels promoting protein kinase C activation in neurons
Correct Answer: B
Rationale:
Chronic hyperglycemia drives glucose into the polyol pathway, where aldose reductase converts it to sorbitol.
Intracellular sorbitol accumulation causes osmotic stress, NADPH depletion, and reduced nitric oxide
synthesis, leading to Schwann cell dysfunction and axonal degeneration. Advanced glycation end-products
(A) contribute to microvascular complications but are not the primary driver of neuropathy. Insulin deficiency
(C) affects glucose uptake but not specifically fatty acid oxidation in Schwann cells. Glucagon (D) is not the
primary mediator of diabetic neuropathy.
WGU D027 - 2026/2027 | Passing Score: 80% | Page 3 of 35
OBJECTIVE ASSESSMENT - EXAM
WGU D027 OA Exam Advanced
Pathopharmacological Foundations
Tested Questions (Latest 2026/2027)
and Verified Rationalized Answers
Advanced Pathopharmacological Foundations | WGU D027 2026/2027
50 100% 2026/2027
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
Cellular Pathophysiology & Genetics Respiratory & Renal Systems
Pharmacokinetics & Pharmacodynamics Endocrine & Immune Disorders
Cardiovascular Pathophysiology Neurological & Musculoskeletal
COVER PAGE - 1
,SECTION 1 | Foundations of Pathophysiology | Q1-Q10 | WGU D027 2026/2027
Q1 Question 1 of 50
A 62-year-old male patient with a 40-pack-year smoking history presents with progressive
dyspnea and a chronic productive cough. His pulmonary function tests reveal an
FEV1/FVC ratio of 0.58 and an FEV1 of 45% predicted. Which pathophysiological
mechanism best explains the progressive airflow limitation in this patient?
A. Destruction of alveolar walls leading to loss of elastic recoil
B. Chronic inflammation causing small airway fibrosis and mucus hypersecretion
C. Bronchial smooth muscle hypertrophy causing episodic bronchospasm
D. Pulmonary capillary endothelial damage leading to interstitial fibrosis
Correct Answer: B
Rationale:
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the small
airways, leading to fibrosis, mucus hypersecretion, and progressive airflow limitation. This matches the
patient's smoking history and fixed airflow obstruction pattern. While alveolar destruction (A) occurs in
emphysema, it is not the primary mechanism of airflow limitation. Episodic bronchospasm (C) is more typical
of asthma. Interstitial fibrosis (D) describes restrictive lung disease, not obstructive.
WGU D027 - 2026/2027 | Passing Score: 80% | Page 1 of 35
,SECTION 1 | Foundations of Pathophysiology | Q1-Q10 | WGU D027 2026/2027
Q2 Question 2 of 50
A 45-year-old female with systemic lupus erythematosus presents with acute onset of
hematuria, proteinuria, and rising serum creatinine. A renal biopsy reveals diffuse
proliferative glomerulonephritis with subendothelial immune complex deposits. Which
complement pathway is primarily activated by these immune complexes?
A. The classical pathway initiated by C1q binding to antibody Fc regions
B. The alternative pathway initiated by spontaneous C3 hydrolysis
C. The lectin pathway initiated by mannose-binding lectin recognition
D. The terminal pathway initiated by direct C5 activation
Correct Answer: A
Rationale:
Immune complex deposition in lupus nephritis activates the classical complement pathway through C1q
binding to the Fc regions of antibodies within the complexes. This leads to C3 convertase formation, C3b
deposition, and subsequent glomerular inflammation. The alternative pathway (B) is antibody-independent
and typically activated by microbial surfaces. The lectin pathway (C) responds to carbohydrate patterns on
pathogens. The terminal pathway (D) requires upstream activation and does not initiate independently.
WGU D027 - 2026/2027 | Passing Score: 80% | Page 2 of 35
, SECTION 1 | Foundations of Pathophysiology | Q1-Q10 | WGU D027 2026/2027
Q3 Question 3 of 50
A 58-year-old male with poorly controlled type 2 diabetes presents with numbness and
tingling in a stocking-glove distribution. Nerve conduction studies reveal slowed
conduction velocities and reduced amplitudes. Which metabolic derangement is the
primary driver of this peripheral neuropathy?
A. Accumulation of advanced glycation end-products causing basement membrane thickening
B. Chronic hyperglycemia leading to sorbitol accumulation via the polyol pathway
C. Insulin deficiency causing impaired fatty acid oxidation in Schwann cells
D. Elevated glucagon levels promoting protein kinase C activation in neurons
Correct Answer: B
Rationale:
Chronic hyperglycemia drives glucose into the polyol pathway, where aldose reductase converts it to sorbitol.
Intracellular sorbitol accumulation causes osmotic stress, NADPH depletion, and reduced nitric oxide
synthesis, leading to Schwann cell dysfunction and axonal degeneration. Advanced glycation end-products
(A) contribute to microvascular complications but are not the primary driver of neuropathy. Insulin deficiency
(C) affects glucose uptake but not specifically fatty acid oxidation in Schwann cells. Glucagon (D) is not the
primary mediator of diabetic neuropathy.
WGU D027 - 2026/2027 | Passing Score: 80% | Page 3 of 35
